ES2119837T3 - Derivados de fenilimidazolidina, su preparacion y su utilizacion. - Google Patents

Derivados de fenilimidazolidina, su preparacion y su utilizacion.

Info

Publication number
ES2119837T3
ES2119837T3 ES93110754T ES93110754T ES2119837T3 ES 2119837 T3 ES2119837 T3 ES 2119837T3 ES 93110754 T ES93110754 T ES 93110754T ES 93110754 T ES93110754 T ES 93110754T ES 2119837 T3 ES2119837 T3 ES 2119837T3
Authority
ES
Spain
Prior art keywords
phenylimidazolidine
derivatives
preparation
nhr
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93110754T
Other languages
English (en)
Inventor
Gerhard Dr Zoller
Bernd Dr Jablonka
Melitta Dr Just
Otmar Dr Klingler
Gerhard Dr Breipohl
Jochen Dr Knolle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2119837T3 publication Critical patent/ES2119837T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/40—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

DERIVADO DE FENILOIMIDAZOLIDINA DE FORMULA (I) QUE PRESENTAN PROPIEDADES FARMACOLOGICAS TOTALES. SIENDO: R1 -NH-C(=NH)-NH2; R,R2,R3 HIDROGENO; R4 -CO-NHR5; -NH-R5 UN RESTO ALFA-AMINOACIDO; Y CH2-CH2-CO-; W HIDROXI; Z OXIGENO Y R 0 A 3.
ES93110754T 1992-07-24 1993-07-06 Derivados de fenilimidazolidina, su preparacion y su utilizacion. Expired - Lifetime ES2119837T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4224414A DE4224414A1 (de) 1992-07-24 1992-07-24 Phenylimidazolidin-derivate, ihre Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
ES2119837T3 true ES2119837T3 (es) 1998-10-16

Family

ID=6463969

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93110754T Expired - Lifetime ES2119837T3 (es) 1992-07-24 1993-07-06 Derivados de fenilimidazolidina, su preparacion y su utilizacion.

Country Status (16)

Country Link
US (1) US5424293A (es)
EP (1) EP0580008B1 (es)
JP (1) JP3775808B2 (es)
KR (1) KR100418321B1 (es)
AT (1) ATE168116T1 (es)
AU (1) AU664630B2 (es)
CA (1) CA2101179C (es)
CZ (1) CZ289297B6 (es)
DE (2) DE4224414A1 (es)
DK (1) DK0580008T3 (es)
ES (1) ES2119837T3 (es)
HU (1) HU220767B1 (es)
IL (1) IL106462A (es)
SK (1) SK282517B6 (es)
TW (1) TW306918B (es)
ZA (1) ZA935341B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4308034A1 (de) * 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
DE4427979A1 (de) 1993-11-15 1996-02-15 Cassella Ag Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5563158A (en) * 1993-12-28 1996-10-08 The Dupont Merck Pharmaceutical Company Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists
ZA963391B (en) * 1995-05-24 1997-10-29 Du Pont Merck Pharma Isoxazoline fibrinogen receptor antagonists.
PT796855E (pt) 1996-03-20 2002-07-31 Hoechst Ag Inibicao da reabsorcao nos ossos e antagonistas de vitronectina
DE19622489A1 (de) 1996-06-05 1997-12-11 Hoechst Ag Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters
DE19647380A1 (de) * 1996-11-15 1998-05-20 Hoechst Ag 5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
DE19647381A1 (de) 1996-11-15 1998-05-20 Hoechst Ag Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
PL323130A1 (en) * 1996-11-15 1998-05-25 Hoechst Ag Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such
DE19741235A1 (de) 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19741873A1 (de) * 1997-09-23 1999-03-25 Hoechst Marion Roussel De Gmbh Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19751251A1 (de) 1997-11-19 1999-05-20 Hoechst Marion Roussel De Gmbh Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
DE19821483A1 (de) 1998-05-14 1999-11-18 Hoechst Marion Roussel De Gmbh Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
US6163155A (en) * 1999-01-28 2000-12-19 Dresser Industries, Inc. Electromagnetic wave resistivity tool having a tilted antenna for determining the horizontal and vertical resistivities and relative dip angle in anisotropic earth formations
DE19922462A1 (de) 1999-05-17 2000-11-23 Aventis Pharma Gmbh Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate
EP1183274A1 (en) 1999-06-17 2002-03-06 Source Precision Medicine, Inc. Method and compounds for inhibiting activity of serine elastases
DE10111877A1 (de) 2001-03-10 2002-09-12 Aventis Pharma Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10137595A1 (de) * 2001-08-01 2003-02-13 Aventis Pharma Gmbh Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung
US8222902B2 (en) * 2006-07-11 2012-07-17 Halliburton Energy Services, Inc. Modular geosteering tool assembly
CA2650481C (en) * 2006-07-12 2013-09-03 Halliburton Energy Services, Inc. Method and apparatus for building a tilted antenna
GB2459067B (en) * 2007-03-16 2011-11-30 Halliburton Energy Serv Inc Robust inversion systems and methods for azimuthally sensitive resistivity logging tools
BRPI0822137B1 (pt) 2008-12-16 2018-10-09 Halliburton Energy Serv Inc conjunto de fundo de furo, e, método de perfilagem
AU2010343292B2 (en) 2010-01-22 2014-10-16 Halliburton Energy Services Inc. Method and apparatus for resistivity measurements
EP2836860A4 (en) 2012-06-25 2015-11-11 Halliburton Energy Services Inc TIP ANTENNA MEASURING SYSTEMS AND METHOD FOR GENERATING ROBUST MEASUREMENT SIGNALS
US10526287B2 (en) 2015-04-23 2020-01-07 Constellation Pharmaceuticals, Inc. LSD1 inhibitors and uses thereof
LT3532459T (lt) 2016-10-26 2023-11-10 Constellation Pharmaceuticals, Inc. Lsd1 inhibitoriai ir jų medicininis panaudojimas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4126277A1 (de) * 1991-08-08 1993-02-11 Cassella Ag Hydantoinderivate
DE4213634A1 (de) * 1992-04-24 1993-10-28 Cassella Ag 2,4-Dioxo-imidazolidin-Derivate

Also Published As

Publication number Publication date
JPH0725855A (ja) 1995-01-27
IL106462A (en) 1997-02-18
HU220767B1 (hu) 2002-05-28
SK282517B6 (sk) 2002-10-08
KR100418321B1 (ko) 2004-05-07
CA2101179A1 (en) 1994-01-25
JP3775808B2 (ja) 2006-05-17
SK76993A3 (en) 1994-04-06
ZA935341B (en) 1994-02-14
EP0580008A3 (de) 1995-03-15
AU664630B2 (en) 1995-11-23
CZ147593A3 (en) 1994-03-16
HUT65141A (en) 1994-04-28
DE59308732D1 (de) 1998-08-13
AU4211993A (en) 1994-01-27
HU9302138D0 (en) 1993-10-28
TW306918B (es) 1997-06-01
US5424293A (en) 1995-06-13
DE4224414A1 (de) 1994-01-27
CA2101179C (en) 2003-10-28
EP0580008B1 (de) 1998-07-08
DK0580008T3 (da) 1999-02-08
EP0580008A2 (de) 1994-01-26
CZ289297B6 (cs) 2001-12-12
IL106462A0 (en) 1993-11-15
KR940005583A (ko) 1994-03-21
ATE168116T1 (de) 1998-07-15

Similar Documents

Publication Publication Date Title
ES2119837T3 (es) Derivados de fenilimidazolidina, su preparacion y su utilizacion.
ATE50763T1 (de) Tetralin-derivate, ihre herstellung und verwendung.
TW248559B (es)
AU7554987A (en) Solutions of oxazaphosphorins having improved stability and process for the preparation thereof
ZA914133B (en) Preparation of substituted piperidines
EP0373549A3 (de) Enzym-hemmende Aminosäurederivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung
HK64691A (en) Anticonvulsant agents
DE3783009D1 (es)
PL312966A1 (en) Derivatives of thiocarbamoil
IE893533L (en) Substituted 3-aminosydnonimines, processes for their¹preparation and their use
AU4370489A (en) The use of oxidized polyamines, especially nn'-bis-(3- propionaldehyde)-1-4-diaminobutane (sperminedialdehyde) as immunosuppressive agents
DE59007185D1 (de) Substituierte 1.2.3.4-Oxatriazolium-5-olate, Verfahren zu ihrer Herstellung und ihre Verwendung.
AU7463487A (en) 3-substituted 1-(2-halogenoalkoxy-benzenesulphonyl)-3- heteroaryl-(thio) ureas
ATE165344T1 (de) Herstellung von symmetrischen und unsymmetrischen disubstituierten n-cyandithioiminocarbonaten
DE69012558T2 (de) Oxidative herstellung von a-nor-17-beta-carboxy-3,5-seco-androstan-5-on-3-säure.
MX9605208A (es) Nuevos derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 580008

Country of ref document: ES